The above two studies suggest that pancreatic cancer cells interact with the tumor microenvironment to open up alternative routes to acquire Asp, allowing pancreatic cancer to bypass the metabolic constraints from GOT2 deficiency. Here, GOT2 is linked to familial pancreatic carcinoma.